Complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: Risk factors for ICU admission and morbidity prognostic score-Reference-Cited by-同舟云学术

Complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: Risk factors for ICU admission and morbidity prognostic score

Published:2016-03 Issue:1 Volume:25 Page:6-15
ISSN:0960-7404
Container-title:Surgical Oncology
language:en
Short-container-title:Surgical Oncology

Author:

Malfroy Sylvain,Wallet Florent,Maucort-Boulch Delphine,Chardonnal Laurent,Sens Nicolas,Friggeri Arnaud,Passot Guillaume,Glehen Olivier,Piriou Vincent

Publisher

Elsevier BV

Subject

Oncology,Surgery

Reference34 articles.

1. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study;Sadeghi;Cancer,2000

2. Peritonectomy procedures;Sugarbaker;Ann. Surg.,1995

3. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study;Glehen;J. Clin. Oncol.,2004

4. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 patients with colorectal cancer with peritoneal carcinomatosis;Esquivel;Ann. Surg. Oncol.,2014

5. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients;Glehen;Cancer,2010

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decision Regret in Patients with Appendiceal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy;Annals of Surgical Oncology;2024-08-27

2. Prognostic Value of the Controlling Nutritional Status (CONUT) Score in Patients Who Underwent Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy;Cancers;2024-07-31

3. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies;Annals of Surgical Oncology;2024-07-22

4. Incidence, risk factors, and outcomes of the transition of HIPEC-induced acute kidney injury to acute kidney disease: a retrospective study;Renal Failure;2024-04-11

5. Is routine admission to a critical care setting following hyperthermic intraperitoneal chemotherapy for ovarian cancer necessary?;European Journal of Surgical Oncology;2023-12